IL102575A - Chiral process and intermediates for the preparation of antidiabetic thiazoles - Google Patents

Chiral process and intermediates for the preparation of antidiabetic thiazoles

Info

Publication number
IL102575A
IL102575A IL10257592A IL10257592A IL102575A IL 102575 A IL102575 A IL 102575A IL 10257592 A IL10257592 A IL 10257592A IL 10257592 A IL10257592 A IL 10257592A IL 102575 A IL102575 A IL 102575A
Authority
IL
Israel
Prior art keywords
compound
formula
borane
methyl
phenyl
Prior art date
Application number
IL10257592A
Other languages
English (en)
Hebrew (he)
Other versions
IL102575A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL102575A0 publication Critical patent/IL102575A0/xx
Publication of IL102575A publication Critical patent/IL102575A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL10257592A 1991-07-22 1992-07-21 Chiral process and intermediates for the preparation of antidiabetic thiazoles IL102575A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73354891A 1991-07-22 1991-07-22

Publications (2)

Publication Number Publication Date
IL102575A0 IL102575A0 (en) 1993-01-14
IL102575A true IL102575A (en) 1996-03-31

Family

ID=24948077

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10257592A IL102575A (en) 1991-07-22 1992-07-21 Chiral process and intermediates for the preparation of antidiabetic thiazoles

Country Status (17)

Country Link
US (1) US5576442A (pt)
EP (1) EP0641331A1 (pt)
JP (1) JP2672029B2 (pt)
KR (1) KR100214907B1 (pt)
AU (1) AU660187B2 (pt)
CA (1) CA2111446C (pt)
FI (1) FI940307A0 (pt)
HU (1) HUT70422A (pt)
IE (1) IE922358A1 (pt)
IL (1) IL102575A (pt)
MX (1) MX9204277A (pt)
NO (1) NO940226D0 (pt)
NZ (1) NZ243652A (pt)
PT (1) PT100709B (pt)
TW (1) TW199892B (pt)
WO (1) WO1993002061A1 (pt)
ZA (1) ZA925470B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687149B1 (fr) * 1992-02-12 1995-11-03 Roussel Uclaf Nouveaux esters pyrethrinouides derives d'alcools thiazoliques, leur procede de preparation et leur application comme pesticides.
JPH08507310A (ja) * 1993-07-16 1996-08-06 ファイザー・インク. チアゾール誘導体のエナンチオ選択的調製

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886814A (en) * 1986-03-13 1989-12-12 Dr. Karl Thomas Gmbh Substituted thiazoles and oxazoles and 2-hydroxy-morpholines
DE3621775A1 (de) * 1986-03-13 1988-01-07 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US4943635A (en) * 1987-08-27 1990-07-24 President & Fellows Of Harvard College Enantioselective reduction of ketones
US5036079A (en) * 1989-12-07 1991-07-30 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
DE69227689T2 (de) * 1991-07-22 1999-04-22 Pfizer Verfahren zur herstellung von (s)-4-[3-(5-methyl-2-phenyl-4-oxazolyl)- 1-hydroxypropyl] brombenzol

Also Published As

Publication number Publication date
AU660187B2 (en) 1995-06-15
AU2306392A (en) 1993-02-23
JPH06505026A (ja) 1994-06-09
HUT70422A (en) 1995-10-30
FI940307A (fi) 1994-01-21
IE922358A1 (en) 1993-01-27
US5576442A (en) 1996-11-19
MX9204277A (es) 1993-02-01
JP2672029B2 (ja) 1997-11-05
NO940226L (no) 1994-01-21
PT100709B (pt) 1999-07-30
NO940226D0 (no) 1994-01-21
IL102575A0 (en) 1993-01-14
FI940307A0 (fi) 1994-01-21
ZA925470B (en) 1994-01-21
EP0641331A1 (en) 1995-03-08
TW199892B (pt) 1993-02-11
KR100214907B1 (ko) 1999-08-02
HU9400187D0 (en) 1994-05-30
PT100709A (pt) 1993-09-30
NZ243652A (en) 1994-02-25
CA2111446C (en) 1997-12-16
WO1993002061A1 (en) 1993-02-04
CA2111446A1 (en) 1993-02-04

Similar Documents

Publication Publication Date Title
US6037505A (en) Enantioselective oxazaborolidine catalysts
EP0640089B1 (en) Enantioselective oxazaborolidine catalysts
US5512689A (en) Process for the preparation of intermediates in the synthesis of chiral thiazolidine-2,4-dione derivatives
AU660187B2 (en) Chiral intermediates for the preparation of antidiabetics thiazoles
RU2150472C1 (ru) Способ получения диизопинокамфеилхлорборана в реакционной смеси, способ восстановления прохирального кетона
JP2001048864A (ja) β−アドレナリン受容体アゴニストの製造用化合物と方法
Meyers et al. Asymmetric addition to chiral aromatic and unsaturated oxazolines using a novel chiral auxiliary
Wu et al. Organolithium in Asymmetric Processes
US5801247A (en) Process for the enantioselective synthesis of hydroxypyrrolidines from amino acids and products thereof
CA1247597A (en) .beta.-LACTAMASE INHIBITING 6-(ALKOXYAMINO- METHYL)PENICILLANIC ACID 1,1-DIOXIDE AND DERIVATIVES
JP5259045B2 (ja) ベンゾプロスタサイクリン中間体、及びそれらの製造方法
US4616092A (en) β-formyl-β-hydroxy ester
DE69729206T2 (de) Oxazolidinverbindungen und verfahren zu ihrer herstellung
Cramer et al. Reductive Asymmetric Aza-Mislow-Evans Rearrangement by 1, 3, 2-Diazaphospholene Catalysis
DE69818039T2 (de) Verfahren zur herstellung von oxiranen,aziridinen und cyclopropanen
JPH0220624B2 (pt)
JPS63211289A (ja) スルタミシリン及び同族体製造用中間体
JPS59144795A (ja) 複素5員環燐誘導体ハロゲン化物
JPS61277673A (ja) 新規チアゾリジン誘導体
JPS58126894A (ja) 2−アゼチジノン誘導体の製法
JPS62209037A (ja) α−ヒドロキシケトン誘導体の製造法
KR20040033345A (ko) 아연 금속의 새로운 활성화 방법

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted
KB Patent renewed
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees